Selenium micronutrient network (WP15)

Homo sapiens

The selenium-centred micronutrient biological network. The most relevant biochemical processes related to selenium in the context of metabolism, oxidation and inflammation are represented. Also, the compartmental separation (intracellular vs. plasma) is presented, identifying the selenium centred plasma metabolome. A selenoprotein database exists at: http://www.selenodb.org. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP15 CPTAC Assay Portal]

Authors

Egoyenechea , Alex Pico , Thomas Kelder , Ben Van Ommen , Chris Evelo , Martijn Van Iersel , Jildau Bouwman , Kristina Hanspers , Damariz Rivero , Andra Waagmeester , Egon Willighagen , Martina Summer-Kutmon , Marianthi Kalafati , Denise Slenter , Eric Weitz , Marvin Martens , and Susan Coort

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Micronutrients

Annotations

Pathway Ontology

classic metabolic pathway selenoamino acid metabolic pathway

Participants

Label Type Compact URI Comment
Lipoxin A4 Metabolite hmdb:HMDB0004385
PGD2 Metabolite hmdb:HMDB0001403 Prostaglandin D2
Arachidonic acid Metabolite hmdb:HMDB0001043
PGE1 Metabolite hmdb:HMDB0001442 Prostaglandin E1
Thromboxane B2 Metabolite hmdb:HMDB0003252
Lipoxin B4 Metabolite hmdb:HMDB0005082
Thromboxane A2 Metabolite hmdb:HMDB0001452
Linoleic acid Metabolite hmdb:HMDB0000673
a-Tocopherol Metabolite hmdb:HMDB0001893
Arachidonic acid Metabolite hmdb:HMDB0001043
Lipoxin A4 Metabolite hmdb:HMDB0004385
F2-Isoprostane Metabolite wikidata:Q33659470
DHA Metabolite hmdb:HMDB0002183 Docosahexaenoic acid
8-Isoprostaglandin F2a Metabolite hmdb:HMDB0005083
PGI2 Metabolite hmdb:HMDB0001335 Prostaglandin I2
PGE2 Metabolite hmdb:HMDB0001220 Prostaglandin E2
Thromboxane B2 Metabolite hmdb:HMDB0003252
MDA Metabolite hmdb:HMDB0006112 Malondialdehyde
PGE2 Metabolite hmdb:HMDB0001220 Prostaglandin E2
a-Tocopherol Metabolite hmdb:HMDB0001893
PGI2 Metabolite hmdb:HMDB0001335 Prostaglandin I2
PGF2a Metabolite hmdb:HMDB0001139 Prostaglandin F2a
DHA Metabolite hmdb:HMDB0002183 Docosahexaenoic acid
ALA Metabolite hmdb:HMDB0001388 Alpha-Linolenic acid
PGF2a Metabolite hmdb:HMDB0001139 Prostaglandin F2a
EPA Metabolite hmdb:HMDB0001999 Eicosapentaenoic acid
PGD2 Metabolite hmdb:HMDB0001403 Prostaglandin D2
Linoleic acid Metabolite hmdb:HMDB0000673
PGE1 Metabolite hmdb:HMDB0001442 Prostaglandin E1
DGLA Metabolite hmdb:HMDB0002925 Dihomo-gamma-linolenic acid
8,11,14-Eicosatrienoic acid
F2-Isoprostane Metabolite wikidata:Q33659470
DPA Metabolite hmdb:HMDB0001976 Docosapentaenoic acid
Lipoxin B4 Metabolite hmdb:HMDB0005082
PGH3 Metabolite hmdb:HMDB0013040 Prostaglandin H3
PGG2 Metabolite hmdb:HMDB0003235 Prostaglandin G2
8-Isoprostaglandin F2a Metabolite hmdb:HMDB0005083
DPA Metabolite hmdb:HMDB0001976 Docosapentaenoic acid
EPA Metabolite hmdb:HMDB0001999 Eicosapentaenoic acid
ALA Metabolite hmdb:HMDB0001388 Alpha-Linolenic acid
MDA Metabolite hmdb:HMDB0006112 Malondialdehyde
PGH2 Metabolite hmdb:HMDB0001381 Prostaglandin H2
PGE3 Metabolite hmdb:HMDB0002664 Prostaglandin E3
Kynurenine Metabolite hmdb:HMDB0000684
Iodine Metabolite wikidata:Q1103
Iodine Metabolite wikidata:Q1103
R-Triiodothyronine (rT3) Metabolite chebi:28774 Reverse triiodothyronine
Triiodothyronine (T3) Metabolite chebi:18258
15-HETE Metabolite hmdb:HMDB0003876 15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid
Thyroxine (T4) Metabolite chebi:30660
5-HPETE Metabolite hmdb:HMDB0001193 5(S)-Hydroperoxyeicosatetraenoic acid
5,6-Epoxytetraene Metabolite kegg.compound:C14815
R-Triiodothyronine (rT3) Metabolite chebi:28774 Reverse triiodothyronine
15-HETE Metabolite hmdb:HMDB0003876 15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid
Triiodothyronine (T3) Metabolite chebi:18258
5-HETE Metabolite hmdb:HMDB0011134 5-hydroxyeicosatetraenoic acid
Thyroxine (T4) Metabolite chebi:30660
5-HETE Metabolite hmdb:HMDB0011134 5-hydroxyeicosatetraenoic acid
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
Uric acid Metabolite hmdb:HMDB0000289
Cysteine Metabolite hmdb:HMDB0000574
H2O2 Metabolite hmdb:HMDB0003125 Hydrogen peroxide
Copper Metabolite hmdb:HMDB0000657
Uric acid Metabolite hmdb:HMDB0000289
Vitamin B12 Metabolite hmdb:HMDB0002174
5,10-Methylene-THF Metabolite hmdb:HMDB0001533 5,10-Methylenetetrahydrofolate
Tryptophan Metabolite hmdb:HMDB0000929
5-methyl-THF Metabolite hmdb:HMDB0001396 5-methyltetrahydrofolate
H2O Metabolite hmdb:HMDB0002111 Glutathione disulfide
Niacinamide Metabolite hmdb:HMDB0001406
Heme Metabolite hmdb:HMDB0003178
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
Lipoic acid Metabolite hmdb:HMDB0001451
Manganese Metabolite hmdb:HMDB0001333
FAD Metabolite hmdb:HMDB0001248 Flavin adenine dinucleotide
Methionine sulfoxide Metabolite hmdb:HMDB0002005
Dehydroascorbic acid Metabolite chebi:17242
Leukotriene A4 Metabolite hmdb:HMDB0001337
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
FAD Metabolite hmdb:HMDB0001248 Flavin adenine dinucleotide
THF Metabolite hmdb:HMDB0001846 Tetrahydrofolic acid
Hydroxykynurenine Metabolite hmdb:HMDB0000732
Folic acid Metabolite hmdb:HMDB0000121
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
Selenium Metabolite hmdb:HMDB0001349
Selenium Metabolite hmdb:HMDB0001349
GSH Metabolite hmdb:HMDB0000125 Glutathione
Calcium Metabolite hmdb:HMDB0000464
Methionine Metabolite hmdb:HMDB0000696
Manganese Metabolite hmdb:HMDB0001333
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
Folic acid Metabolite hmdb:HMDB0000121
FMN Metabolite hmdb:HMDB0001520 Flavin Mononucleotide
Selenocysteine Metabolite hmdb:HMDB0003288
Selenide Metabolite chebi:15076
Selenophosphate Metabolite chebi:16144
Cysteine Metabolite hmdb:HMDB0000574
Leukotriene C4 Metabolite hmdb:HMDB0001198
Leukotriene C4 Metabolite hmdb:HMDB0001198
Dehydroascorbic acid Metabolite chebi:17242
Ascorbic acid Metabolite chebi:29073
Lipoic acid Metabolite hmdb:HMDB0001451
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
Homocysteine Metabolite hmdb:HMDB0000742
ROS Metabolite chebi:26523 reactive oxygen species
http://en.wikipedia.org/wiki/Reactive_Oxygen_Species
RNS Metabolite chebi:62764 reactive nitrogen species
http://en.wikipedia.org/wiki/Reactive_nitrogen_species
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
Vitamin B12 Metabolite hmdb:HMDB0002174
Homocysteine Metabolite hmdb:HMDB0000742
Pyridoxal 5'-phosphate Metabolite hmdb:HMDB0001491
Serine Metabolite hmdb:HMDB0000187
Iron Metabolite wikidata:Q26840996
Hypoxanthine Metabolite hmdb:HMDB0000157
VLDL Metabolite chebi:39027 very-low-density lipoprotein
LDL Metabolite chebi:39026 low-density lipoprotein
Cholesterol Metabolite hmdb:HMDB0000067
HDL Metabolite chebi:39025 high-density lipoprotein
VLDL-TAG Metabolite chebi:47776 very-low-density lipoprotein-triglyceride
Triglyceride transport
FMN Metabolite hmdb:HMDB0001520 Flavin Mononucleotide
HDL-C Metabolite chebi:47775 high-density lipoprotein cholesterol
Cholesterol transport
TAG Metabolite chebi:17855 Triglyceride
Triacylglycerol
HDL Metabolite chebi:39025 high-density lipoprotein
HDL-C Metabolite chebi:47775 high-density lipoprotein cholesterol
VLDL Metabolite chebi:39027 very-low-density lipoprotein
oxLDL Metabolite chebi:60151 oxidized low-density lipoprotein
HDL/APOA1 Metabolite chebi:39025 high-density lipoprotein
ApoA-I is present on the majority of HDL particles and constitutes aprox 70% of the apolipoprotein content of HDL particles
HDL/SAA Metabolite chebi:39025 high-density lipoprotein
SAA circulates in plasma as a constituent of high density lipoproteins (HDL).
Cholesterol Metabolite hmdb:HMDB0000067
oxLDL Metabolite chebi:60151 oxidized low-density lipoprotein
TAG Metabolite chebi:17855 Triglyceride
Triacylglycerol
LDL Metabolite chebi:39026 low-density lipoprotein
VLDL-TAG Metabolite chebi:47776 very-low-density lipoprotein-triglyceride
Triglyceride transport
VLDL/APOB Metabolite chebi:39027 very-low-density lipoprotein
The VLDL is produced in the liver, contains one molecule of apoB100
O2 Metabolite hmdb:HMDB0001377
Pyridoxal 5'-phosphate Metabolite hmdb:HMDB0001491
8-OHdG Metabolite hmdb:HMDB0003333 8-Hydroxy-deoxyguanosine
8-OHdG Metabolite hmdb:HMDB0003333 8-Hydroxy-deoxyguanosine
FAD Metabolite hmdb:HMDB0001248 Flavin adenine dinucleotide
ADP Metabolite hmdb:HMDB0001341 Adenosine diphosphate
Leukotriene D4 Metabolite hmdb:HMDB0003080
Leukotriene D4 Metabolite hmdb:HMDB0003080
Copper Metabolite hmdb:HMDB0000657
Chlorine Metabolite hmdb:HMDB0000492
Chlorine Metabolite hmdb:HMDB0000492
Cystathionine Metabolite hmdb:HMDB0000099
FAD Metabolite hmdb:HMDB0001248 Flavin adenine dinucleotide
Dihydrolipoate Metabolite hmdb:HMDB0012210
Serine Metabolite hmdb:HMDB0000187
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
ATP Metabolite hmdb:HMDB0000538 Adenosine triphosphate
Zinc Metabolite hmdb:HMDB0015532
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
GSSG Metabolite hmdb:HMDB0000656 Glutathione disulfide
NADPH Metabolite hmdb:HMDB0000221 Nicotinamide adenine dinucleotide phosphate-Reduced
Zinc Metabolite hmdb:HMDB0015532
Niacin Metabolite hmdb:HMDB0001488
Leukotriene B4 Metabolite hmdb:HMDB0001085
Leukotriene B4 Metabolite hmdb:HMDB0001085
Quinolinic Acid Metabolite hmdb:HMDB0000232
PMP Metabolite hmdb:HMDB0001555 Pyridoxamine 5'-phosphate
NO Metabolite hmdb:HMDB0003378 Nitric oxide
O3 Metabolite chebi:25812 ozone
NO Metabolite hmdb:HMDB0003378 Nitric oxide
HNO2 Metabolite chebi:25567 Nitrous acid
NO2 Metabolite chebi:33101 Nitrogen dioxide
HOCl Metabolite hmdb:HMDB0001050 Hypochlorite
NADP+ Metabolite hmdb:HMDB0000217 Nicotinamide adenine dinucleotide phosphate-Oxidized
GSH Metabolite hmdb:HMDB0000125 Glutathione
Fibrin Metabolite wikidata:Q27205
Riboflavin Metabolite hmdb:HMDB0000244
Ascorbate Metabolite chebi:38290
O2-radical (aka Hyperoxid or superoxide) Metabolite hmdb:HMDB0002168 Superoxide
Xanthine Metabolite hmdb:HMDB0000292
Calcium Metabolite hmdb:HMDB0000464
Methionine Metabolite hmdb:HMDB0000696
ADP Metabolite hmdb:HMDB0001341 Adenosine diphosphate
Nitrotyrosine Metabolite hmdb:HMDB0001904
ONOO-/ONOOH Metabolite hmdb:HMDB0002179 Peroxynitrite
Nitrotyrosine Metabolite hmdb:HMDB0001904
ATP Metabolite hmdb:HMDB0000538 Adenosine triphosphate
Leukotriene E4 Metabolite hmdb:HMDB0002200
Leukotriene E4 Metabolite hmdb:HMDB0002200
Leukotriene F4 Metabolite hmdb:HMDB0006465
Glucose Metabolite hmdb:HMDB0000122
Fructosamine Metabolite hmdb:HMDB0002030
Fructosamine Metabolite hmdb:HMDB0002030
Iron Metabolite wikidata:Q26840996
Hypoxanthine Metabolite hmdb:HMDB0000157
Ascorbic acid Metabolite chebi:29073
RELA GeneProduct ncbigene:5970 nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65
NFKB1 GeneProduct ncbigene:4790 nuclear factor NF-kappa-B p50 subunit
NFKB2 GeneProduct ncbigene:4791 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
FGA Protein ensembl:ENSG00000171560
COX2 Protein ncbigene:5743 EC 1.14.99.1
Cyclooxygenase 2
COX-2 inducible
COX1 Protein ncbigene:5742 EC 1.14.99.1
Cyclooxygenase 1
COX-1 constitutive
MTR Protein ncbigene:4548 EC 2.1.1.13
5-methyltetrahydrofolate-homocysteine methyltransferase
TRXR1 Protein ncbigene:7296 EC 1.8.1.9
Selenoprotein-thioredoxin reductase 1
CBS Protein ncbigene:875 EC 4.2.1.22
cystathionine-beta-synthase
KMO Protein ncbigene:8564 EC 1.14.13.9
kynurenine 3-hydroxylase
MPO Protein ncbigene:4353 EC 1.11.1.7
Myeloperoxidase
Catalase Protein ncbigene:847 EC 1.11.1.6
MPO Protein ncbigene:4353 EC 1.11.1.7
Myeloperoxidase
Factor VII Protein ncbigene:2155 EC 3.4.21.21
coagulation factor VII (serum prothrombin conversion accelerator)
Thrombin Protein ncbigene:2147 EC 3.4.21.5
coagulation factor II (thrombin)
tPA Protein ncbigene:5327 EC 3.4.21.68
plasminogen activator, tissue
tPA Protein ncbigene:5327 EC 3.4.21.68
plasminogen activator, tissue
PAI-1 Protein ncbigene:5054 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
PLG Protein ncbigene:5340 EC 3.4.21.7
Plasminogen
Thrombin Protein ncbigene:2147 EC 3.4.21.5
coagulation factor II (thrombin)
Factor VII Protein ncbigene:2155 EC 3.4.21.21
coagulation factor VII (serum prothrombin conversion accelerator)
PLG Protein ncbigene:5340 EC 3.4.21.7
Plasminogen
PAI-1 Protein ncbigene:5054 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
GGT1 Protein ncbigene:2678 EC 2.3.2.2
gamma-glutamyltransferase 1
GPX 4 Protein ncbigene:2879 EC 1.11.1.12
Selenoprotein-glutathione peroxidase 4
TRXR2 Protein ncbigene:10587 EC 1.8.1.9
Selenoprotein-thioredoxin reductase 2
Xantine oxidase Protein ncbigene:7498 EC 1.17.3.2
http://en.wikipedia.org/wiki/Xanthine_oxidase
PRDX5 Protein ncbigene:25824 EC 1.11.1.15
peroxiredoxin 5
ALOX5 Protein ncbigene:240 EC 1.13.11.34
arachidonate 5-lipoxygenase
ALOX15B Protein ncbigene:247 EC 1.13.11.33
arachidonate 15-lipoxygenase, type B
SelR Protein ncbigene:51734 EC 1.8.4.-
Selenoprotein-selenoprotein X
SOD3 Protein ncbigene:6649 EC 1.15.1.1
superoxide dismutase 3, extracellular
PRDX1 Protein ncbigene:5052 EC 1.11.1.15
peroxiredoxin 1
RFK Protein ncbigene:55312 EC 2.7.1.26
riboflavin kinase
GPX 3 Protein ncbigene:2878 EC 1.11.1.9
Selenoprotein-glutathione peroxidase 3
CTH Protein ncbigene:1491 EC 4.4.1.1
cystathionase
PNPO Protein ncbigene:55163 EC 1.4.3.5
pyridoxamine 5'-phosphate oxidase
SelK Protein ncbigene:58515 Selenoprotein-selenoprotein K
Sep15 Protein ncbigene:9403 Selenoprotein-15 kDa selenoprotein
GPX 6 Protein ncbigene:257202 EC 1.11.1.9
Selenoprotein-glutathione peroxidase 6
Nicotinamidase Protein eccode:3.5.1.19 Catalysis of the reaction: nicotinamide + H2O = nicotinate + NH3 GO:0008936
GPX 3 Protein ncbigene:2878 Selenoprotein-glutathione peroxidase 3
GPX 2 Protein ncbigene:2877 EC 1.11.1.9
Selenoprotein-glutathione peroxidase 2
SelP Protein ncbigene:6414 Selenoprotein-selenoprotein P
Trx-S2 Protein ncbigene:7295 oxidized thioredoxin
PRDX4 Protein ncbigene:10549 EC 1.11.1.15
peroxiredoxin 4
GPX 1 Protein ncbigene:2876 EC 1.11.1.9
Selenoprotein-glutathione peroxidase 1
MTHFR Protein ncbigene:4524 EC 1.5.1.20
5,10-methylenetetrahydrofolate reductase
SelH Protein ncbigene:280636 Selenoprotein-selenoprotein H-chromosome 11 open reading frame 31
SPS2 Protein ncbigene:22928 EC2.7.9.3
Selenoprotein-selenophosphate synthetase 2
SelO Protein ncbigene:83642 Selenoprotein-selenoprotein O
Unknown function
SelN Protein ncbigene:57190 Selenoprotein-selenoprotein N, 1
DIO2 Protein ncbigene:1734 EC 1.97.1.10
Selenoprotein-deiodinase, iodothyronine, type II
SelT Protein ncbigene:51714 Selenoprotein-selenoprotein T
SelM Protein ncbigene:140606 Selenoprotein-selenoprotein M
SelP Protein ncbigene:6414 Selenoprotein-selenoprotein P
DIO3 Protein ncbigene:1735 EC 1.97.1.11
Selenoprotein-deiodinase, iodothyronine type III
DIO1 Protein ncbigene:1733 EC 1.97.1.10
Selenoprotein-deiodinase, iodothyronine, type I
SelV Protein ncbigene:348303 Selenoprotein-selenoprotein V
Unknown function
SelI Protein ncbigene:85465 Selenoprotein-selenoprotein I
Unknown function
SelS Protein ncbigene:55829 Selenoprotein-selenoprotein S
SOD1 Protein ncbigene:6647 EC 1.15.1.1
superoxide dismutase 1, soluble
PRDX3 Protein ncbigene:10935 EC 1.11.1.15
peroxiredoxin 3
GSR Protein ncbigene:2936 EC 1.8.1.7
glutathione reductase
APOA1 Protein ncbigene:335 apolipoprotein A-I
APOB Protein ncbigene:338 apolipoprotein B
LDLR Protein ncbigene:3949 low density lipoprotein receptor
SAA4 Protein ncbigene:6291 serum amyloid A4, constitutive
SRB1 Protein ncbigene:949 scavenger receptor class B, member 1
ABCA1 Protein ncbigene:19 ATP-binding cassette, sub-family A (ABC1), member 1
APOA1-NO2Tyr Protein ncbigene:335 Nitrotyrosinated apolipoprotein A-I
ACT Protein ncbigene:12 alpha-1-antichymotrypsin
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
SAA2 Protein ncbigene:6289 serum amyloid A2
ACT Protein ncbigene:12 alpha-1-antichymotrypsin
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
APOA1 Protein ncbigene:335 apolipoprotein A-I
SAA1 Protein ncbigene:6288 serum amyloid A1
SAA3 Protein ncbigene:6290 serum amyloid A3 pseudogene
APOB Protein ncbigene:338 apolipoprotein B
PRDX2 Protein ncbigene:7001 EC 1.11.1.15
peroxiredoxin 2
SOD2 Protein ncbigene:6648 EC 1.15.1.1
superoxide dismutase 2, mitochondrial
sICAM-1 Protein ncbigene:3383 soluble intercellular adhesion molecule 1
IL10 Protein ncbigene:3458 interferon, gamma
TNFa Protein ncbigene:7124 tumor necrosis factor (TNF superfamily, member 2)
IFNg Protein ncbigene:3458 interferon, gamma
ALB Protein ncbigene:213 albumin
INS Protein ncbigene:3630 Insulin
IL1B Protein ncbigene:3553 interleukin 1, beta
INSR Protein ncbigene:3643 Insulin receptor
HBB Protein ncbigene:3043 hemoglobin, beta
TNFa Protein ncbigene:7124 tumor necrosis factor (TNF superfamily, member 2)
CRP Protein ncbigene:1401 C-reactive protein, pentraxin-related
Fibrin Protein wikidata:Q27205
IL1B Protein ncbigene:3553 interleukin 1, beta
IFNg Protein ncbigene:3458 interferon, gamma
sICAM-1 Protein ncbigene:3383 soluble intercellular adhesion molecule 1
CCL2 Protein ncbigene:6347 chemokine (C-C motif) ligand 2
INS Protein ncbigene:3630 Insulin
IL10 Protein ncbigene:3458 interferon, gamma
ALB Protein ncbigene:213 albumin
FLAP Protein ncbigene:241 arachidonate 5-lipoxygenase-activating protein
IL6 Protein ncbigene:3569 interleukin 6 (interferon, beta 2)
CCL2 Protein ncbigene:6347 chemokine (C-C motif) ligand 2
IL6 Protein ncbigene:3569 interleukin 6 (interferon, beta 2)
HBA1 Protein ncbigene:3039 hemoglobin, alpha 1
SelW Protein ncbigene:6415 Selenoprotein-selenoprotein W
SOD3 Protein ncbigene:6649 EC 1.15.1.1
superoxide dismutase 3, extracellular
TRXR1 Protein ncbigene:7296 Selenoprotein-thioredoxin reductase 1
Kynureninase Protein ncbigene:8942 EC 3.7.1.3
Trx-(SH)2 Protein ncbigene:7295 reduced thioredoxin
TRXR3 Protein ncbigene:114112 EC 1.8.1.9
Selenoprotein-thioredoxin reductase 3
FLAD1 Protein ncbigene:80308 EC 2.7.7.2
FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae)
FGB Protein ensembl:ENSG00000171564
FGG Protein ensembl:ENSG00000171557

References

  1. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H. Proc Natl Acad Sci U S A. 1979 Feb;76(2):944–8. PubMed Europe PMC Scholia
  2. Inhibition of human neutrophil superoxide generation by alpha 1-antichymotrypsin. Kilpatrick L, Johnson JL, Nickbarg EB, Wang ZM, Clifford TF, Banach M, et al. J Immunol. 1991 Apr 1;146(7):2388–93. PubMed Europe PMC Scholia
  3. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione. Huwyler J, Bürgin M, Zeugin T, Gut J. Mol Pharmacol. 1991 Mar;39(3):314–23. PubMed Europe PMC Scholia
  4. Conversion of linoleic acid into arachidonic acid by cultured murine and human keratinocytes. Isseroff RR, Ziboh VA, Chapkin RS, Martinez DT. J Lipid Res. 1987 Nov;28(11):1342–9. PubMed Europe PMC Scholia
  5. Urinary 8-hydroxy-2’-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Shigenaga MK, Gimeno CJ, Ames BN. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9697–701. PubMed Europe PMC Scholia
  6. Vitamin E: interactions with free radicals and ascorbate. McCay PB. Annu Rev Nutr. 1985;5:323–40. PubMed Europe PMC Scholia
  7. Vitamin B-12: plant sources, requirements, and assay. Herbert V. Am J Clin Nutr. 1988 Sep;48(3 Suppl):852–8. PubMed Europe PMC Scholia
  8. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Reilly IA, FitzGerald GA. Blood. 1987 Jan;69(1):180–6. PubMed Europe PMC Scholia
  9. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. Clifton PM, Mackinnon AM, Barter PJ. J Lipid Res. 1985 Dec;26(12):1389–98. PubMed Europe PMC Scholia
  10. Acyl-donor specificities of partially purified 1-acylglycerophosphate acyltransferase, 2-acylglycerophosphate acyltransferase and 1-acylglycerophosphorylcholine acyltransferase from rat-liver microsomes. Yamashita S, Hosaka K, Numa S. Eur J Biochem. 1973 Sep 21;38(1):25–31. PubMed Europe PMC Scholia
  11. Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids. Anderson ME, Allison RD, Meister A. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1088–91. PubMed Europe PMC Scholia
  12. Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone. Denis D, Charleson S, Rackham A, Jones TR, Ford-Hutchinson AW, Lord A, et al. Prostaglandins. 1982 Dec;24(6):801–14. PubMed Europe PMC Scholia
  13. Leukotrienes. Hammarström S. Annu Rev Biochem. 1983;52:355–77. PubMed Europe PMC Scholia
  14. Biochemistry of tryptophan in health and disease. Bender DA. Mol Aspects Med. 1983;6(2):101–97. PubMed Europe PMC Scholia
  15. alpha-Lipoic acid as a biological antioxidant. Packer L, Witt EH, Tritschler HJ. Free Radic Biol Med. 1995 Aug;19(2):227–50. PubMed Europe PMC Scholia
  16. Towards the physiological function of uric acid. Becker BF. Free Radic Biol Med. 1993 Jun;14(6):615–31. PubMed Europe PMC Scholia
  17. 5-lipoxygenase-activating protein is an arachidonate binding protein. Mancini JA, Abramovitz M, Cox ME, Wong E, Charleson S, Perrier H, et al. FEBS Lett. 1993 Mar 8;318(3):277–81. PubMed Europe PMC Scholia
  18. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products. Schnurr K, Belkner J, Ursini F, Schewe T, Kühn H. J Biol Chem. 1996 Mar 1;271(9):4653–8. PubMed Europe PMC Scholia
  19. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Arnér ES, Nordberg J, Holmgren A. Biochem Biophys Res Commun. 1996 Aug 5;225(1):268–74. PubMed Europe PMC Scholia
  20. Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism? Guimarães MJ, Peterson D, Vicari A, Cocks BG, Copeland NG, Gilbert DJ, et al. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15086–91. PubMed Europe PMC Scholia
  21. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Hussein O, Rosenblat M, Refael G, Aviram M. Transplantation. 1997 Mar 15;63(5):679–85. PubMed Europe PMC Scholia
  22. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Serhan CN. Prostaglandins. 1997 Feb;53(2):107–37. PubMed Europe PMC Scholia
  23. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. May JM, Mendiratta S, Hill KE, Burk RF. J Biol Chem. 1997 Sep 5;272(36):22607–10. PubMed Europe PMC Scholia
  24. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, et al. J Biol Chem. 1997 Nov 21;272(47):29911–8. PubMed Europe PMC Scholia
  25. Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase. Imai H, Narashima K, Arai M, Sakamoto H, Chiba N, Nakagawa Y. J Biol Chem. 1998 Jan 23;273(4):1990–7. PubMed Europe PMC Scholia
  26. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. Gladyshev VN, Jeang KT, Wootton JC, Hatfield DL. J Biol Chem. 1998 Apr 10;273(15):8910–5. PubMed Europe PMC Scholia
  27. Pharmacological inhibition of leukotriene actions. Engels F, Nijkamp FP. Pharm World Sci. 1998 Apr;20(2):60–5. PubMed Europe PMC Scholia
  28. The metabolism of homocysteine: pathways and regulation. Finkelstein JD. Eur J Pediatr. 1998 Apr;157 Suppl 2:S40-4. PubMed Europe PMC Scholia
  29. Anxiety and adipose essential fatty acid precursors for prostaglandin E1 and E2. Mamalakis G, Kafatos A, Tornaritis M, Alevizos B. J Am Coll Nutr. 1998 Jun;17(3):239–43. PubMed Europe PMC Scholia
  30. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Wu D, Mura C, Beharka AA, Han SN, Paulson KE, Hwang D, et al. Am J Physiol. 1998 Sep;275(3):C661-8. PubMed Europe PMC Scholia
  31. Cyclooxygenase in biology and disease. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. FASEB J. 1998 Sep;12(12):1063–73. PubMed Europe PMC Scholia
  32. Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer’s disease. Janciauskiene S, Wright HT. Bioessays. 1998 Dec;20(12):1039–46. PubMed Europe PMC Scholia
  33. Lipid peroxidation-DNA damage by malondialdehyde. Marnett LJ. Mutat Res. 1999 Mar 8;424(1–2):83–95. PubMed Europe PMC Scholia
  34. In vivo conversion of linoleic acid to arachidonic acid in human adults. Salem N Jr, Pawlosky R, Wegher B, Hibbeln J. Prostaglandins Leukot Essent Fatty Acids. 1999;60(5–6):407–10. PubMed Europe PMC Scholia
  35. Tissue-specific functions of individual glutathione peroxidases. Brigelius-Flohé R. Free Radic Biol Med. 1999 Nov;27(9–10):951–65. PubMed Europe PMC Scholia
  36. Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Al-Obaidi MK, Philippou H, Stubbs PJ, Adami A, Amersey R, Noble MM, et al. Circulation. 2000 Feb 1;101(4):372–7. PubMed Europe PMC Scholia
  37. The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. Hesse-Bähr K, Dreher I, Köhrle J. Biofactors. 2000;11(1–2):83–5. PubMed Europe PMC Scholia
  38. Free radicals and hearing. Cause, consequence, and criteria. Evans P, Halliwell B. Ann N Y Acad Sci. 1999 Nov 28;884:19–40. PubMed Europe PMC Scholia
  39. Nitric oxide is a physiological substrate for mammalian peroxidases. Abu-Soud HM, Hazen SL. J Biol Chem. 2000 Dec 1;275(48):37524–32. PubMed Europe PMC Scholia
  40. Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin. Abate A, Yang G, Dennery PA, Oberle S, Schröder H. Free Radic Biol Med. 2000 Dec;29(11):1135–42. PubMed Europe PMC Scholia
  41. Selenoprotein W: a review. Whanger PD. Cell Mol Life Sci. 2000 Dec;57(13–14):1846–52. PubMed Europe PMC Scholia
  42. Does inflammation contribute to thrombotic events? Esmon CT. Haemostasis. 2000;30 Suppl 2:34–40. PubMed Europe PMC Scholia
  43. Properties and biological activities of thioredoxins. Powis G, Montfort WR. Annu Rev Pharmacol Toxicol. 2001;41:261–95. PubMed Europe PMC Scholia
  44. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Diabetes Metab Res Rev. 2001;17(2):94–8. PubMed Europe PMC Scholia
  45. Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Maccarrone M, Meloni C, Manca-di-Villahermosa S, Cococcetta N, Casciani CU, Finazzi-Agrò A, et al. Am J Kidney Dis. 2001 May;37(5):964–9. PubMed Europe PMC Scholia
  46. Why there are two cyclooxygenase isozymes. Smith WL, Langenbach R. J Clin Invest. 2001 Jun;107(12):1491–5. PubMed Europe PMC Scholia
  47. Elements of the fibrinolytic system. Lijnen HR. Ann N Y Acad Sci. 2001;936:226–36. PubMed Europe PMC Scholia
  48. Inhibition of type 2,5’-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue. Molnár I, Balázs C, Szegedi G, Sipka S. Immunol Lett. 2002 Jan 1;80(1):3–7. PubMed Europe PMC Scholia
  49. The covalent FAD of monoamine oxidase: structural and functional role and mechanism of the flavinylation reaction. Edmondson DE, Newton-Vinson P. Antioxid Redox Signal. 2001 Oct;3(5):789–806. PubMed Europe PMC Scholia
  50. Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element. Korotkov KV, Novoselov SV, Hatfield DL, Gladyshev VN. Mol Cell Biol. 2002 Mar;22(5):1402–11. PubMed Europe PMC Scholia
  51. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Circ Res. 2002 Feb 22;90(3):297–304. PubMed Europe PMC Scholia
  52. Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over. Bates CJ, Thane CW, Prentice A, Delves HT. J Trace Elem Med Biol. 2002;16(1):1–8. PubMed Europe PMC Scholia
  53. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Levin G, Duffin KL, Obukowicz MG, Hummert SL, Fujiwara H, Needleman P, et al. Biochem J. 2002 Jul 15;365(Pt 2):489–96. PubMed Europe PMC Scholia
  54. Selenoprotein W is a glutathione-dependent antioxidant in vivo. Jeong D won, Kim TS, Chung YW, Lee BJ, Kim IY. FEBS Lett. 2002 Apr 24;517(1–3):225–8. PubMed Europe PMC Scholia
  55. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, et al. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1402–8. PubMed Europe PMC Scholia
  56. Prostaglandin E synthase. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandins Other Lipid Mediat. 2002 Aug;68–69:383–99. PubMed Europe PMC Scholia
  57. Prostaglandin F synthase. Watanabe K. Prostaglandins Other Lipid Mediat. 2002 Aug;68–69:401–7. PubMed Europe PMC Scholia
  58. Thromboxane synthase: structure and function of protein and gene. Wang LH, Kulmacz RJ. Prostaglandins Other Lipid Mediat. 2002 Aug;68–69:409–22. PubMed Europe PMC Scholia
  59. Mechanism of metal activation of human hematopoietic prostaglandin D synthase. Inoue T, Irikura D, Okazaki N, Kinugasa S, Matsumura H, Uodome N, et al. Nat Struct Biol. 2003 Apr;10(4):291–6. PubMed Europe PMC Scholia
  60. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. Burk RF, Hill KE, Motley AK. J Nutr. 2003 May;133(5 Suppl 1):1517S-20S. PubMed Europe PMC Scholia
  61. Characterization of mammalian selenoproteomes. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigó R, et al. Science. 2003 May 30;300(5624):1439–43. PubMed Europe PMC Scholia
  62. 5-lipoxygenase and FLAP. Peters-Golden M, Brock TG. Prostaglandins Leukot Essent Fatty Acids. 2003;69(2–3):99–109. PubMed Europe PMC Scholia
  63. Ligand binding-induced conformational changes in riboflavin kinase: structural basis for the ordered mechanism. Karthikeyan S, Zhou Q, Osterman AL, Zhang H. Biochemistry. 2003 Nov 4;42(43):12532–8. PubMed Europe PMC Scholia
  64. Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants. Sneddon AA, Wu HC, Farquharson A, Grant I, Arthur JR, Rotondo D, et al. Atherosclerosis. 2003 Nov;171(1):57–65. PubMed Europe PMC Scholia
  65. A study on soluble intercellular adhesion molecule-1 and selenium in patients with rheumatoid arthritis complicated by vasculitis. Witkowska AM, Kuryliszyn-Moskal A, Borawska MH, Hukałowicz K, Markiewicz R. Clin Rheumatol. 2003 Dec;22(6):414–9. PubMed Europe PMC Scholia
  66. Enzymology of NAD+ homeostasis in man. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, Ruggieri S. Cell Mol Life Sci. 2004 Jan;61(1):19–34. PubMed Europe PMC Scholia
  67. Nitric oxide and superoxide in inflammation and immune regulation. Guzik TJ, Korbut R, Adamek-Guzik T. J Physiol Pharmacol. 2003 Dec;54(4):469–87. PubMed Europe PMC Scholia
  68. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress - SelS is a novel glucose-regulated protein. Gao Y, Feng HC, Walder K, Bolton K, Sunderland T, Bishara N, et al. FEBS Lett. 2004 Apr 9;563(1–3):185–90. PubMed Europe PMC Scholia
  69. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. Nature. 2004 Jun 24;429(6994):841–7. PubMed Europe PMC Scholia
  70. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, et al. J Clin Invest. 2004 Aug;114(4):529–41. PubMed Europe PMC Scholia
  71. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Simmons DL, Botting RM, Hla T. Pharmacol Rev. 2004 Sep;56(3):387–437. PubMed Europe PMC Scholia
  72. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer’s disease. Schöneich C. Biochim Biophys Acta. 2005 Jan 17;1703(2):111–9. PubMed Europe PMC Scholia
  73. Heterogeneity and function of mammalian MSRs: enzymes for repair, protection and regulation. Hansel A, Heinemann SH, Hoshi T. Biochim Biophys Acta. 2005 Jan 17;1703(2):239–47. PubMed Europe PMC Scholia
  74. Myeloperoxidase: friend and foe. Klebanoff SJ. J Leukoc Biol. 2005 May;77(5):598–625. PubMed Europe PMC Scholia
  75. Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication. Doo YC, Han SJ, Park WJ, Kim SM, Choi SH, Cho GY, et al. Clin Cardiol. 2005 Jan;28(1):47–51. PubMed Europe PMC Scholia
  76. Cyclooxygenases, peroxide tone and the allure of fish oil. Smith WL. Curr Opin Cell Biol. 2005 Apr;17(2):174–82. PubMed Europe PMC Scholia
  77. Fibrinogen and fibrin. Weisel JW. Adv Protein Chem. 2005;70:247–99. PubMed Europe PMC Scholia
  78. Simultaneous determination of unbound thyroid hormones in human plasma using high performance frontal analysis with electrochemical detection. Kimura T, Nakanishi K, Nakagawa T, Shibukawa A, Matsuzaki K. J Pharm Biomed Anal. 2005 Jun 15;38(2):204–9. PubMed Europe PMC Scholia
  79. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Lewis GF, Rader DJ. Circ Res. 2005 Jun 24;96(12):1221–32. PubMed Europe PMC Scholia
  80. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. J Biol Chem. 2005 Oct 28;280(43):35890–5. PubMed Europe PMC Scholia
  81. Selenium, the thyroid, and the endocrine system. Köhrle J, Jakob F, Contempré B, Dumont JE. Endocr Rev. 2005 Dec;26(7):944–84. PubMed Europe PMC Scholia
  82. The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy. Kovacs E. Biomed Pharmacother. 2005 Oct;59(9):498–500. PubMed Europe PMC Scholia
  83. NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. Ferguson AD, Labunskyy VM, Fomenko DE, Araç D, Chelliah Y, Amezcua CA, et al. J Biol Chem. 2006 Feb 10;281(6):3536–43. PubMed Europe PMC Scholia
  84. Blocking tumor cell eicosanoid synthesis by GP x 4 impedes tumor growth and malignancy. Heirman I, Ginneberge D, Brigelius-Flohé R, Hendrickx N, Agostinis P, Brouckaert P, et al. Free Radic Biol Med. 2006 Jan 15;40(2):285–94. PubMed Europe PMC Scholia
  85. Myeloperoxidase metabolizes thiocyanate in a reaction driven by nitric oxide. Galijasevic S, Saed GM, Hazen SL, Abu-Soud HM. Biochemistry. 2006 Jan 31;45(4):1255–62. PubMed Europe PMC Scholia
  86. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Gao Y, Hannan NRF, Wanyonyi S, Konstantopolous N, Pagnon J, Feng HC, et al. Cytokine. 2006 Mar 7;33(5):246–51. PubMed Europe PMC Scholia
  87. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Malle E, Marsche G, Arnhold J, Davies MJ. Biochim Biophys Acta. 2006 Apr;1761(4):392–415. PubMed Europe PMC Scholia
  88. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. Agaugué S, Perrin-Cocon L, Coutant F, André P, Lotteau V. J Immunol. 2006 Aug 15;177(4):2061–71. PubMed Europe PMC Scholia
  89. Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. Lu C, Qiu F, Zhou H, Peng Y, Hao W, Xu J, et al. FEBS Lett. 2006 Oct 2;580(22):5189–97. PubMed Europe PMC Scholia
  90. Deiodinases: implications of the local control of thyroid hormone action. Bianco AC, Kim BW. J Clin Invest. 2006 Oct;116(10):2571–9. PubMed Europe PMC Scholia
  91. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Videla LA, Rodrigo R, Araya J, Poniachik J. Trends Mol Med. 2006 Dec;12(12):555–8. PubMed Europe PMC Scholia
  92. Glutathione peroxidases and redox-regulated transcription factors. Brigelius-Flohé R. Biol Chem. 2006;387(10–11):1329–35. PubMed Europe PMC Scholia
  93. Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. Scheurig AC, Thorand B, Fischer B, Heier M, Koenig W. Eur J Clin Nutr. 2008 Jan;62(1):127–37. PubMed Europe PMC Scholia
  94. The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. Labunskyy VM, Hatfield DL, Gladyshev VN. IUBMB Life. 2007 Jan;59(1):1–5. PubMed Europe PMC Scholia
  95. Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation. Ben Jilani KE, Panee J, He Q, Berry MJ, Li PA. Int J Biol Sci. 2007 Feb 11;3(4):198–204. PubMed Europe PMC Scholia
  96. Serum selenium and diabetes in U.S. adults. Bleys J, Navas-Acien A, Guallar E. Diabetes Care. 2007 Apr;30(4):829–34. PubMed Europe PMC Scholia
  97. Vitamin E regulatory mechanisms. Traber MG. Annu Rev Nutr. 2007;27:347–62. PubMed Europe PMC Scholia
  98. From selenium to selenoproteins: synthesis, identity, and their role in human health. Papp LV, Lu J, Holmgren A, Khanna KK. Antioxid Redox Signal. 2007 Jul;9(7):775–806. PubMed Europe PMC Scholia
  99. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation. Karpe F, Bickerton AS, Hodson L, Fielding BA, Tan GD, Frayn KN. Biochem Soc Trans. 2007 Jun;35(Pt 3):472–6. PubMed Europe PMC Scholia
  100. Selenoprotein H is a redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification. Panee J, Stoytcheva ZR, Liu W, Berry MJ. J Biol Chem. 2007 Aug 17;282(33):23759–65. PubMed Europe PMC Scholia
  101. Properties of an unusual heme cofactor in PLP-dependent cystathionine beta-synthase. Singh S, Madzelan P, Banerjee R. Nat Prod Rep. 2007 Jun;24(3):631–9. PubMed Europe PMC Scholia
  102. Glucose metabolism and catecholamines. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, et al. Crit Care Med. 2007 Sep;35(9 Suppl):S508-18. PubMed Europe PMC Scholia
  103. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Kalpakcioglu B, Senel K. Clin Rheumatol. 2008 Feb;27(2):141–5. PubMed Europe PMC Scholia
  104. Serum selenium concentrations correlate significantly with inflammatory biomarker high-sensitive CRP levels in Hungarian gestational diabetic and healthy pregnant women at mid-pregnancy. Molnar J, Garamvolgyi Z, Herold M, Adanyi N, Somogyi A, Rigo J Jr. Biol Trace Elem Res. 2008 Jan;121(1):16–22. PubMed Europe PMC Scholia
  105. Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change. Li YC, Chiang CW, Yeh HC, Hsu PY, Whitby FG, Wang LH, et al. J Biol Chem. 2008 Feb 1;283(5):2917–26. PubMed Europe PMC Scholia
  106. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. Grumolato L, Ghzili H, Montero-Hadjadje M, Gasman S, Lesage J, Tanguy Y, et al. FASEB J. 2008 Jun;22(6):1756–68. PubMed Europe PMC Scholia
  107. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Cipollone F, Cicolini G, Bucci M. Pharmacol Ther. 2008 May;118(2):161–80. PubMed Europe PMC Scholia
  108. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. Bosschaerts T, Guilliams M, Noel W, Hérin M, Burk RF, Hill KE, et al. J Immunol. 2008 May 1;180(9):6168–75. PubMed Europe PMC Scholia
  109. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Banning A, Florian S, Deubel S, Thalmann S, Müller-Schmehl K, Jacobasch G, et al. Antioxid Redox Signal. 2008 Sep;10(9):1491–500. PubMed Europe PMC Scholia
  110. Evolution of catalases from bacteria to humans. Zamocky M, Furtmüller PG, Obinger C. Antioxid Redox Signal. 2008 Sep;10(9):1527–48. PubMed Europe PMC Scholia
  111. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Basu S. Antioxid Redox Signal. 2008 Aug;10(8):1405–34. PubMed Europe PMC Scholia
  112. Oxidative stress in normal and impaired wound repair. Schäfer M, Werner S. Pharmacol Res. 2008 Aug;58(2):165–71. PubMed Europe PMC Scholia
  113. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Ho AWY, Wong CK, Lam CWK. Immunobiology. 2008;213(7):533–44. PubMed Europe PMC Scholia
  114. Pyridoxine 5’-phosphate oxidase, not pyridoxal kinase, involves in long-term potentiation induction in the rat dentate gyrus. Kwak SE, Kim JE, Kim DW, Kwon OS, Choi SY, Kang TC. Hippocampus. 2009 Jan;19(1):45–56. PubMed Europe PMC Scholia
  115. Selenoproteins. Lu J, Holmgren A. J Biol Chem. 2009 Jan 9;284(2):723–7. PubMed Europe PMC Scholia
  116. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Moreno JJ. Biochem Pharmacol. 2009 Jan 1;77(1):1–10. PubMed Europe PMC Scholia
  117. FoxO1 integrates insulin signaling to VLDL production. Kamagate A, Dong HH. Cell Cycle. 2008 Oct;7(20):3162–70. PubMed Europe PMC Scholia
  118. The controversial place of vitamin C in cancer treatment. Verrax J, Calderon PB. Biochem Pharmacol. 2008 Dec 15;76(12):1644–52. PubMed Europe PMC Scholia
  119. Oxidative modification of LDL: its pathological role in atherosclerosis. Itabe H. Clin Rev Allergy Immunol. 2009 Aug;37(1):4–11. PubMed Europe PMC Scholia
  120. Fructosamine--an underutilized tool in diabetes management: case report and literature review. Youssef D, El Abbassi A, Jordan RM, Peiris AN. Tenn Med. 2008 Nov;101(11):31–3. PubMed Europe PMC Scholia
  121. Protection against reactive oxygen species by selenoproteins. Steinbrenner H, Sies H. Biochim Biophys Acta. 2009 Nov;1790(11):1478–85. PubMed Europe PMC Scholia
  122. Structure and mechanism of a eukaryotic FMN adenylyltransferase. Huerta C, Borek D, Machius M, Grishin NV, Zhang H. J Mol Biol. 2009 Jun 5;389(2):388–400. PubMed Europe PMC Scholia
  123. Studies of biomarker responses to intervention with riboflavin: a systematic review. Hoey L, McNulty H, Strain JJ. Am J Clin Nutr. 2009 Jun;89(6):1960S-1980S. PubMed Europe PMC Scholia
  124. Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. Hoey L, Strain JJ, McNulty H. Am J Clin Nutr. 2009 Jun;89(6):1981S-1996S. PubMed Europe PMC Scholia
  125. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism? Wu C, Bates SM. Pol Arch Med Wewn. 2009 Apr;119(4):225–30. PubMed Europe PMC Scholia
  126. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. Abello N, Kerstjens HAM, Postma DS, Bischoff R. J Proteome Res. 2009 Jul;8(7):3222–38. PubMed Europe PMC Scholia
  127. Role of the MTHFR polymorphisms in cancer risk modification and treatment. Kim YI. Future Oncol. 2009 May;5(4):523–42. PubMed Europe PMC Scholia
  128. Selenoprotein expression and function-selenoprotein W. Whanger PD. Biochim Biophys Acta. 2009 Nov;1790(11):1448–52. PubMed Europe PMC Scholia
  129. Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment. Arbogast S, Beuvin M, Fraysse B, Zhou H, Muntoni F, Ferreiro A. Ann Neurol. 2009 Jun;65(6):677–86. PubMed Europe PMC Scholia
  130. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Lavie CJ, Milani RV, Mehra MR, Ventura HO. J Am Coll Cardiol. 2009 Aug 11;54(7):585–94. PubMed Europe PMC Scholia
  131. Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. Adams RLC, Bird RJ. Nephrology (Carlton). 2009 Aug;14(5):462–70. PubMed Europe PMC Scholia
  132. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN. Antioxid Redox Signal. 2010 Apr 1;12(7):839–49. PubMed Europe PMC Scholia
  133. Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Arbogast S, Ferreiro A. Antioxid Redox Signal. 2010 Apr 1;12(7):893–904. PubMed Europe PMC Scholia
  134. Proinflammatory cytokines in CRP baseline regulation. Eklund CM. Adv Clin Chem. 2009;48:111–36. PubMed Europe PMC Scholia
  135. Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study. Joensen AM, Schmidt EB, Dethlefsen C, Johnsen SP, Tjønneland A, Rasmussen LH, et al. Br J Nutr. 2010 Feb;103(4):602–7. PubMed Europe PMC Scholia